Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Combining scalp reduction and hair transplants improves coverage and appearance for male baldness.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Dermal fibroblasts have adjustable roles in wound healing, with specific cells promoting regeneration or scar formation.

A new sheep gene, KRTAP36-1, may help breed sheep with better wool by reducing prickle factor.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

A mutation in the KRT25 gene causes woolly hair and hair loss.

Hair restoration surgery techniques have evolved, with focus on patient selection and realistic goals, and future advancements may include cloning and gene therapy.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Mettl3 is essential for normal tissue development and self-renewal by regulating gene expression.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

A genetic mutation in the EDA gene causes hypohidrotic ectodermal dysplasia in cats.

A compromised gut may trigger the autoimmune hair loss condition Alopecia Areata.